Wed, March 28, 2012
Tue, March 27, 2012
Mon, March 26, 2012
Sun, March 25, 2012
Sat, March 24, 2012
Fri, March 23, 2012
Thu, March 22, 2012
Wed, March 21, 2012
Tue, March 20, 2012
Mon, March 19, 2012
Sun, March 18, 2012
Fri, March 16, 2012
Thu, March 15, 2012
Wed, March 14, 2012

Astex Pharmaceuticals Announces March 27th Analyst and Investor Day Agenda


//health-fitness.news-articles.net/content/2012/ .. -march-27th-analyst-and-investor-day-agenda.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


DUBLIN, Calif.--([ ])--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor Day webcast, to take place from 10 am to 12 pm ET on Tuesday, March 27th in New York.

Investors and interested parties may access the webcast in the Investor Events section of the Company's website, [ www.astx.com ]. A webcast replay will be available for 90 days following the live event.

10:00 (5 min.) Welcome and Introductions

Timothy L. Enns
SVP, Corporate Communications and Marketing

10:05 (15 min.) Corporate Overview

James S. J. Manuso, Ph.D.
Chairman and Chief Executive Officer

10:20 (15 min.) Financial Overview

Michael Molkentin, C.P.A.
Chief Financial Officer and Corporate Secretary

10:35 (15 min.)

10:50 (20 min.)

Clinical Update


SGI-110 & HMAs

Mohammad Azab, M.D.
Chief Medical Officer

Jean-Pierre Issa, MD
Fels Institute of Cancer Research
Temple University, Philadelphia, PA

11:10 (20 min.) AT 13387 & HSP90 inhibitors

Andrew Wagner, MD, PhD
Dana Farber Cancer Institute, Boston, MA

11:30 (15 min.)

11:45 (15 min.)

Research & Discovery


Partnering & Corporate Development

Harren Jhoti, Ph.D.
President and Director

Martin Buckland
Chief Business Officer

12:00 (5 min.) Closing Remarks

James S. J. Manuso, Ph.D.
Chairman and Chief Executive Officer

The times listed above are approximate and are subject to change.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit [ http://www.astx.com ].


Publication Contributing Sources